The Story Behind Imatinib, the First Targeted Cancer Treatment episode artwork

EPISODE · May 6, 2025 · 26 MIN

The Story Behind Imatinib, the First Targeted Cancer Treatment

from The Good News About Cancer

Before the early 2000s, there were no effective treatments for chronic myelogenous leukemia, a blood cancer. Then came Imatinib. This drug dramatically improved survival and quality of life for patients with this disease. It also ushered in a new era of cancer treatment, with drugs that directly target tumor cells. In this episode, Chuck and Alicia talk with Dr. Brian Druker, a renowned physician scientist who was the main force behind the development of Imatinib.

NOW PLAYING

The Story Behind Imatinib, the First Targeted Cancer Treatment

0:00 26:59

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Good News About Cancer?

This episode is 26 minutes long.

When was this The Good News About Cancer episode published?

This episode was published on May 6, 2025.

What is this episode about?

Before the early 2000s, there were no effective treatments for chronic myelogenous leukemia, a blood cancer. Then came Imatinib. This drug dramatically improved survival and quality of life for patients with this disease. It also ushered in a new...

Can I download this The Good News About Cancer episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!